<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00835965</url>
  </required_header>
  <id_info>
    <org_study_id>Merck-Chamchad-2008</org_study_id>
    <secondary_id>Merck #32589</secondary_id>
    <nct_id>NCT00835965</nct_id>
  </id_info>
  <brief_title>Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries</brief_title>
  <official_title>A Randomized, Double-Blind Comparison of Oral Aprepitant and Lower Dose Dexamethasone vs Aprepitant Alone for Preventing Postoperative Nausea and Vomiting After Elective Laparoscopic Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Main Line Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Drexel University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Main Line Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The combination of aprepitant and lower dose dexamethasone is superior to aprepitant alone
      with respect to the proportion of patients with a complete response (no vomiting and no use
      of rescue therapy) during 24 hours after the placement of last suture/staple.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative Nausea and Vomiting (PONV) is a serious and common (50%-70%) complication of
      laparoscopic abdominal surgery. PONV is multifactorial, and the treatment is multimodal.
      Preoperative treatment should target the specific mechanism of PONV to minimize its
      incidence/consequences to the benefit of the patients.

      Aprepitant, a selective antagonist of neurokinin-1 (NK-1) receptors, blocks the emetic
      effects of substance P.5 Substance P action on the NK-1 receptors in the central nervous
      system (CNS) is one of the final pathways to an emetic response. Dexamethasone is an
      inexpensive and effective antiemetic drug with minimal side effects after a single-dose
      administration. The commonly used minimal effective dose is 8 to 10 mg, but the dose 5 mg is
      suggested for PONV in patients undergoing laparoscopic surgeries. Based on the literature
      review, occurrence of PONV does not significantly differ at dosing of Dexamethasone equal or
      higher than 4 mg.

      This study compares the incidence of nausea, vomiting, need for rescue medication, prolonged
      PACU time, and unplanned hospital admission in patients with high risk for PONV treated with
      oral aprepitant and dexamethasone or aprepitant alone preoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2009</start_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidences of nausea, vomiting, need for rescue medication</measure>
    <time_frame>1 hour, 2 hours, 24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidences of unplanned hospital admission; duration of PACU stay</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive aprepitant and dexamethasone for prevention of postoperative nausea and vomiting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receiving aprepitant and placebo dexamethasone for prevention of postoperative nausea and vomiting</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone 5 mg administered intravenously following endotracheal intubation</description>
    <arm_group_label>Active Comparator</arm_group_label>
    <other_name>EMEND</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aprepitant</intervention_name>
    <description>Aprepitant 40mg PO one time at least one hour prior to induction of anesthesia</description>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <other_name>EMEND</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Dexamethasone</intervention_name>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years old

          -  ASA physical status I-III

          -  must have at least 2 risk factors for PONV

        Exclusion Criteria:

          -  pregnant or breast feeding patients

          -  antiemetic medication in previous 24 hours

          -  allergy or other contraindication to study medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dmitri Chamchad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lankenau Hospital, Lankenau Institute for Medical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dmitri Chamchad, MD</last_name>
    <phone>610-645-6866</phone>
    <email>chamchad@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mikhail Medved, PhD</last_name>
    <phone>610-645-6866</phone>
    <email>MedvedM@MLHS.ORG</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lankenau Hospital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <last_update_submitted>February 3, 2009</last_update_submitted>
  <last_update_submitted_qc>February 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dmitri Chamchad, MD</name_title>
    <organization>Main Line Health System, Lankenau Hospital</organization>
  </responsible_party>
  <keyword>Laparoscopic</keyword>
  <keyword>Surgery</keyword>
  <keyword>Postoperative</keyword>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Aprepitant</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Postoperative Nausea, Postoperative Vomiting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Aprepitant</mesh_term>
    <mesh_term>Fosaprepitant</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 9, 2011</submitted>
    <returned>March 3, 2011</returned>
    <submitted>June 16, 2011</submitted>
    <returned>July 14, 2011</returned>
    <submitted>July 20, 2011</submitted>
    <returned>August 12, 2011</returned>
    <submitted>July 3, 2015</submitted>
    <returned>July 30, 2015</returned>
    <submitted>September 30, 2017</submitted>
    <returned>October 30, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

